Minerva Neurosciences, Inc

The momentum for this stock is not very good. Minerva Neurosciences, Inc is not very popular among insiders. Minerva Neurosciences, Inc is a mediocre stock to choose.

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the deve...

News

Minerva Neurosciences (NASDAQ:NERV) Receives New Coverage from Analysts at StockNews.com

Ticker Report StockNews.com assumed coverage on shares of Minerva Neurosciences (NASDAQ:NERV - Free Report) in a report released on Saturday. The brokerage issued a sell rating on the biopharmaceutical company's...\n more…

Minerva Neurosciences (NASDAQ:NERV) Research Coverage Started at StockNews.com

Zolmax StockNews.com initiated coverage on shares of Minerva Neurosciences (NASDAQ:NERV - Get Free Report) in a research note issued on Saturday. The firm set a "sell" rating on the biopharmaceutical...\n more…

Minerva Neurosciences (NASDAQ:NERV) Coverage Initiated by Analysts at StockNews.com

Ticker Report StockNews.com initiated coverage on shares of Minerva Neurosciences (NASDAQ:NERV - Free Report) in a report published on Friday morning. The brokerage issued a sell rating on the biopharmaceutical...\n more…

Minerva Neurosciences (NASDAQ:NERV) Stock Price Passes Below Two Hundred Day Moving Average of $3.24

Ticker Report Minerva Neurosciences, Inc. (NASDAQ:NERV - Get Free Report) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $3.24 and traded as...\n more…

Minerva Neurosciences (NASDAQ:NERV) Receives New Coverage from Analysts at StockNews.com

Zolmax Analysts at StockNews.com began coverage on shares of Minerva Neurosciences (NASDAQ:NERV - Get Free Report) in a report released on Friday. The firm set a "sell" rating on the biopharmaceutical...\n more…

Minerva Neurosciences (NASDAQ:NERV) and AC Immune (NASDAQ:ACIU) Financial Comparison

Ticker Report Minerva Neurosciences (NASDAQ:NERV - Get Free Report) and AC Immune (NASDAQ:ACIU - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two...\n more…